a Background: Assembly of human immunodeficiency virus type 1 (HIV-1) occurs at the level of the plasma membrane of the host cell. During this process HIV incorporates significant quantities of cell surface-derived molecules into its lipid bilayer including human leucocyte antigen (HLA) class I and II, intercellular adhesion molecule-1 and lymphocyte function antigen-1. Several studies indicate that virionbound host-cell-derived molecules are functional and affect the biological properties of HIV-1. Virion-associated HLA class II and intercellular adhesion molecule-1 enhance the infectivity of T-cell line-adapted (TCLA) viruses. No role for virionassociated HLA class I molecules has yet been identified.
Objective: To investigate the role of HLA class I molecules in HIV replication and infectivity
Methods: HLA class I negative human cells lines transfected with the HLA Cw4 gene were infected with different TCLA viruses as well as primary X4 isolates. The infectivity of HLA Cw4 positive and negative viruses was determined on indicator cell lines and on phytohaemagglutinin-activated peripheral blood mononuclear cells. An entry polymerase chain reaction assay was used to determine differences in entrycompetence of Cw4 positive and negative viruses. The expression of selected gp120 epitopes on native Env molecules derived from Cw4 positive and negative viruses was determined by a monoclonal antibody-based enzyme-linked immunosorbent assay.
Immunoprecipitation experiments were performed to investigate the presence of gp120/HLA Cw4 complexes. Neutralization assays determined the differences in susceptibility to neutralization between HLA Cw4 negative and positive viruses.
Results and conclusions:
The infectivity of primary HIV-1 X4 isolates and of TCLA viruses is increased upon viral incorporation of HLA Cw4 molecules. This effect is associated with changes in viral envelope proteins conformation including an enhanced expression of the V3 loop of gp120, and of epitopes that are exposed upon CD4 binding. The gp120 conformational changes are consistent with the formation of a multimolecular complex between HLA class I and gp120/160. HLA Cw4 incorporation is also associated to a lower susceptibility to antibody neutralization. These findings have important implications for understanding the immune response to cryptic and conformational epitopes of the viral envelope.
Introduction
The HIV envelope glycoprotein consists of two noncovalently associated subunits, a surface glycoprotein, gp120 and a transmembrane glycoprotein gp41. Different regions of gp120 bind to either the CD4 receptor or one of the chemokine coreceptors on target cells. Upon binding to CD4, gp120 undergoes conformational changes that facilitate subsequent interactions with the coreceptor. Interaction with the coreceptor induces further conformational changes in the envelope protein and exposure of the fusion domain of gp41, which then mediates fusion of the cellular and viral membranes [1] . Host-cell-derived molecules are acquired by the virus during maturation and budding and contribute to HIV infectivity. For example, virionic human leucocyte antigen (HLA) class II and intercellular adhesion molecule-1, bind to their specific cellular ligands and increase the affinity of the virus for the cell [2] . HIV also incorporates significant quantities of HLA class I molecules whose function in infectivity is still unclear. To address the role of HLA class I molecules in virus infectivity we have used the human lymphoblastoid cell line LCL.721.221 which lacks classical HLA class I heavy chain -A, -B and -C genes [3] and expressed constitutively the HIV coreceptor CXCR4. LCL.721.221 cells transfected with the HLA class I Cw4 allele and with the human CD4 gene (.221.Cw4) or with CD4 only (.221) were used to produce HLA Cw4 positive and negative viruses. The kinetics of replication and the infectivity of the progeny viruses were determined on cell lines and peripheral blood mononuclear cells (PBMC) infectivity assays. Native envelope proteins derived from HLA Cw4 positive and negative viruses were analysed for the expression of conformational determinants using specific monoclonal antibodies (mAbs).
Materials and methods

Cells and reagents
The human B-lymphoblastoid cell lines LCL 721.221 and LCL 721.221 Cw4, a generous gift of R. Biassoni, were transfected with the human CD4 gene cloned into pcDNA1 vector. MAbs A32, C11, and 1.7b were from J. E. Robinson [4] ; mAbs CRA3, CRA4, 2G12 and 136.1 were from NIBSC [5, 6] ; mAbs T9 and P4D10 were from Britta Wharen [7] . Rabbit serum directed to HIV-1 gp120 envelope protein was purchased from Intracel Corporation. Mab L31 was directed to HLA C heavy chains [8] . The T-cell lineadapted (TCLA) strain HIV-1 LAI was propagated in the T cell line CEM. Bru [9] , NL4-3 [10] and NDK [11] viruses were produced by transfection of U293 cell line with provirus molecular clones. Primary isolates 248, 215, #22 and #26 were isolated from patient's PBMC by coculture with phytohaemagglutinin (PHA)-activated PBMC from healthy blood donors in our laboratory. Primary isolate designated ETS was from Dr. F. Brun-Vézinet. Bx26 sequential sera were previously described [12] .
Kinetic of infection and infectivity assay
The .221 or .221.Cw4 cells were infected with 2 ng p24 equivalent/10 6 cells. The kinetic of infection was followed by measurement of HIV-1 p24 antigen (HIV-1 core profile ELISA, Dupont de Nemours, Les Ullis, France) or reverse transcriptase activity (Retrosys, Innovagen, Lund, Sweden). The HeLa-CD4-LTRlacZ P4 (HeLa P4) indicator cell line [13] was utilized to determine virus infectivity. HeLa P4 carry the bacterial lacZ gene, encoding the enzyme β-galactosidase (β-Gal), under the transcriptional control of the HIV-1 long terminal repeat (LTR). The β-Gal activity is induced by Tat upon expression of a newly formed provirus, and serves as a measure of virus infectivity. Viruses were tested at different dilutions as previously described [13] .
Entry polymerase chain reaction detection of strong stop HIV DNA The .221 and .221.Cw4 cells were incubated for 2 h at 37°C with DNAse-treated HIV containing supernatant at a multiplicity of infection (MOI) of 1 (20 µg/ml DNAse Boehringer-Mannheim, Germany in 10 mM MgCl 2 , 30 min at 30°C)., washed, trypsinized (trypsine XIII, 15 µg/ml, Sigma, St. Louis, MO, USA) in serum-free medium, washed again and resuspended in 10% fetal calf serum-RPMI medium for a further incubation of 36 h at 37°C. Virus supernatants were then collected, filtered and added to .221.Cw4 cells for entry polymerase chain reaction (PCR) assay. Cells were collected at different times, centrifuged and lysed in 400 µl of 25 mM Tris-HCl pH 8, 125 mM KCl, 0.2% Nonidet P-40 (NP-40), 0.5 mg/ml proteinase K (Boehringer-Mannheim) followed by an incubation at 56°C for 3 h. Lysates (25 µl) were used for the PCR reaction. The primers used were, in R sequence, sense primer: 5′ggctaactagggaacccactg3′; in U5 sequence, anti-sense primer: 5′ctgctagagattttccacactgac3′. The hybridization probe used was LTR 3: 5′gtgtgtgcccgtct-gttgtgtg3′. The PCR reaction was performed in a Perkin-Elmer instrument (Perkin-Elmer, Branchburg, NJ, USA) and the product separated by agarose gel electrophoresis, transfered to a membrane and hybridized with the specific probe. gp120 capture ELISA assay gp120 was captured to the solid phase via a lectin, Galantus nivalis agglutinin (GNA) from snowdrop bulbs, that recognizes a specific glycane structure expressed on envelope glycoproteins of HIV-1, HIV-2 and SIV. The assay was carried out as previously described [14] . GNA was coated on 96-Starwell plate (Nunc, Roskilde, Denmark) at a concentration of 10 µg/ml. Virus supernatants were lysed in phosphatebuffered saline containing 0.25% Empigen and 0.5% bovine serum albumin and incubated overnight at 4°C. As a control of mAbs specificity, non-infected cell culture supernatants were always tested in the same plate. MAbs were incubated for 2 h followed by secondary anti-IgG antibodies conjugated to horseradish peroxidase (HRP). Orthophenyl diamine with H 2 O 2 was used as substrate and the reaction stopped with 2.5 M H 2 SO 4 . The absorbance was read at 290 nm/620 nm.
Immunoprecipitation
The .221.Cw4 and .221 cells were infected with HIV-1 LAI and surface biotinylated by addition of 0.15 mg/ml NHS-biotin (Pierce, Rockford, IL, USA) to 1 × 10 7 cells/ml in 0.1 M Hepes pH 8.0, 0.15 M NaCl for 30 min on ice. The reaction was quenched with 10 mM NH 4 Cl and cells were washed and lysed in 0.5% NP-40. Lysates were immunoprecipitated with the anti HLA-C mAb L31, and the LAI gp120-specific mAb P4D10 plus a control mAb using a procedure previously described [15] . Immunoprecipitated material was resolved by sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (7.5% gel), proteins were transferred to nitrocellulose and probed with streptavidin-HRP for detection by an enhanced chemiluminescence system (Amersham, Little Chalfont, UK). Alternatively NP-40 lysates of LAI-infected or -uninfected .221.Cw4 and .221 unlabeled cells were immunoprecipitated with L31 and P4D10 mAbs. After SDS polyacrylamide gel and transfer to nitrocellulose membrane the immunoprecipitated material was probed with mAb L31 (1/50 dilution of ascitic fluid) to detect HLA Cw4 and mAb P4D10 (20 µg/ml) to detect LAI Env glycoproteins.
Neutralization assays
Neutralizing activities of human seropositive sera were determined with PBMC as target cells and HIV-1 primary isolates. The assay combined serial dilutions of virus with serial dilutions of serum and is based on detecting a 10-fold virus titre reduction by the immune serum. The neutralization assay on HeLa P4 cells was performed in 96-well flat-bottom tissue culture plates by adding 0.4 ng reverse transcriptase of HLA Cw4 positive or negative viruses in 50 µl together with 50 µl of serial dilutions of sera. After 1 h at 37°C the mixture was added on a monolayer of HeLa P4 cells. Indicator cells and viruses were incubated for 48 h, washed and lysed in 100 µl of a buffer containing 0.125% NP-40 and 50 mM β-mercaptoethanol. Virus infectivity was then determined by measuring β-Gal activity in cell lysates by colorimetry at 540 nm, using 100 µl of a 6 mM solution of chlorophenol red-beta-D-galactopyranoside (Boehringer Mannheim).
Results and discussion
The kinetics of replication of four HIV-1 TCLA strain, LAI, Bru, NL4-3 and NDK were determined on LCL.721.221 cells transfected with the HLA class I Cw4 allele and with the human CD4 gene (.221.Cw4) and compared with those obtained on LCL.721.221 transfected with CD4 only (.221). For NL4-3 and NDK there were no significant differences in the kinetics of growth on .221 compared with .221.Cw4 cells. In contrast, growth of both LAI and Bru was significantly delayed on .221 compared with .221.Cw4 cells. Five primary isolates were tested, four of them were X4 (ETS, 248, 215 and #26) and one (#22) was dual tropic X4/R5. All of the five isolates replicated only on .221.Cw4 cells (Fig. 1a) .
In order to evaluate the infectivity of viruses generated from .221 and .221.Cw4 cells, virus supernatants collected at the peak of infection were added to HeLa P4 indicator cell line and virus entry determined by the colorimetric determination of β-Gal activity in cell extracts (Fig. 1b) . LAI generated on .221.Cw4 cells was 30 times more infectious compared with LAI generated on .221 cells. The infectivity of Bru generated on .221.Cw4 cells was three times enhanced compared with that of the same virus grown on .221 cells, whereas there were no significative differences in the infectivity of NL4-3 and NDK. The presence of virusassociated HLA class I molecules within viruses generated from .221.Cw4 cells was controlled by Western blot analysis on all viral preparations (data not shown).
To test whether the increased infectivity of HLA Cw4 positive viruses was also detectable on activated human T cells we performed PBMC infectivity assays. Two LAI virus stocks generated from 221. and 221.Cw4 cells were titrated on PHA-activated PBMC. The ratio between the tissue culture infectious dose (TCID 50 ) and the amount of p24 antigen used for the virus inoculum was 7 and 19 TCID 50 /ng p24 for LAI propagated on .221. and 49 and 122 for LAI propagated on 221.Cw4 cells.
To test whether incorporation of HLA Cw4 enhances virus entry in the target cells we performed an entry PCR assay with viruses generated from a single round of replication in .221 and .221.Cw4 cells (Fig. 1c) . We tested LAI, which infectivity is increased by HLA Cw4, NDK which is not affected by HLA Cw4 and one of the primary X4 isolates (248). LAI generated on .221.Cw4 cells displayed a more rapid kinetic and an increased level of strong stop DNA compared to LAI generated on .221 cells whereas there was no significant difference in the entry kinetic of the other TCLA virus tested, NDK. Similarly to LAI, the entry of the primary isolate 248 derived from .221.Cw4 cells was also accelerated. These data are consistent with the kinetic of replication of the three viruses on .221 and .221.Cw4 cells.
Taken together the data showed that incorporation of HLA Cw4 enhances infectivity by increasing the efficiency of viral entry. This effect is particularly evident for the primary X4 isolates and for the TCLA viruses LAI and Bru whereas the two other TCLA viruses tested are not affected by HLA Cw4 incorporation.
Other cell surface molecules, such as HLA class II and intercellular adhesion molecule-1 are incorporated into the virus and increase its infectivity by binding to their specific cellular ligands on the target cell [16, 17] . This could not be the case of HLA class I, since its natural ligand, CD8, is not normally expressed by cells susceptible to HIV (CD4 positive). Therefore, we speculated that incorporation of HLA Cw4 molecules within mature viral particles may be followed by changes in the structure of the viral envelope glycoproteins. The expression of different structural epitopes by native gp120 derived from HLA Cw4 positive and negative viruses was tested using a lectin-based gp120-capture ELISA assay and a panel of mAbs that were specific for different gp120 epitopes. Our analysis was restricted to gp120 from LAI, Bru and NL4-3 viruses since the majority of mAbs tested did not recognize NDK gp120. In each experiment, the amount of gp120 captured to the solid phase was equalized using a polyclonal anti-gp120 serum. As shown in Fig. 2 mAb P4D10, which is specific for the V3 loop, showed an increased binding to gp120 derived from HLA Cw4 positive compared to HLA Cw4 negative LAI and Bru viruses whereas it bound equally well to Cw4 positive and negative NL4-3 gp120. MAb 1.7b, directed toward a broadly neutralizing epitope which is more exposed upon engagement of CD4, [CD4-induced (CD4i) epitopes mAb] showed the same pattern of reactivity as P4D10, namely, it was increased on Cw4 positive compared to Cw4 negative LAI and Bru gp120. MAb 136.1, directed to a C3 linear epitope expressed only on denatured gp120, showed the opposite pattern of reactivity, since it was only weakly reactive with gp120 derived from HLA Cw4 positive viruses and showed an increased reactivity on HLA Cw4 negative Bru and LAI. Also in this case there were no significant differences between NL4-3 gp120 preparations. Other mAbs directed to discontinuous shown. A rabbit polyclonal anti-gp120 serum was used to control for the total amount of gp120 captured to the solid phase. Similar results were obtained in three independent experiments.
epitopes were also tested and showed no significant differences in binding to gp120 from Cw4 positive and negative viruses: T9 (C1), A32 (C1-C4), C11 (C1-C5), CRA3 (V2), CRA4 (V2) and 2G12 (C3-V4). As an example, the reactivity of mAb T9 is shown in Fig. 2 .
The differences within the V3 loop and CD4i epitope expression were observed only on gp120 derived from LAI and Bru grown on Cw4 positive cells but not NL4-3 whose infectivity is not influenced by the incorporation of HLA Cw4. The V3 loop and the CD4i epitope are known to be important in gp120-coreceptor interaction. Both CD4i and V3 antibodies disrupt the binding of gp120-CD4 complexes to the coreceptor [18, 19] . The CD4i epitope is masked by the flanking V2 and V3 loops and CD4 binding repositions the V1/V2 loops, thus exposing the CD4i epitopes [4] and allowing a better interaction with the coreceptor [20] . A more favourable orientation of the V3 loop in HLA Cw4 positive LAI and Bru could account for their increased competence to enter target cells. Furthemore, a partial repositioning of the V1/V2 loops, which facilitates chemokine receptor binding, could be induced in these viruses by the presence of HLA Cw4 molecules. Interestingly, the increased reactivity of 
ence of partially denatured or partially processed envelope proteins on Cw4 negative LAI and Bru viruses.
To explain the gp120 conformational changes observed on LAI and Bru HLA Cw4 positive viruses we speculated that HLA Cw4 molecules and Env may physically interact during the process of virus maturation and budding. Therefore, we tested the presence of HLA Cw4/gp120 complexes on LAI-infected cells. Cells were surface biotinylated and the cell lysates immunoprecipitated with either mAb L31 (an anti-HLA C heavy chain mAb) or mAb P4D10 (Fig. 3a) . Immunoprecipitation of LAI-infected .221 cells with P4D10 revealed, in addition to gp120 and gp160, two proteins of 55 and 48 kDa, the first corresponding to CD4. The P4D10 immunoprecipitate of LAI-infected .221.Cw4 cells exhibited all of the above bands plus an additional band of 45 kDa corresponding to the same band precipitated by L31 on both infected and noninfected cells. A weak 160 kDa band was seen in the L31 immunoprecipitate of .221.Cw4 LAI infected cells. To identify the 45 kDa band as HLA Cw4 heavy chain we performed the same experiment without biotin surface labelling and we probed the nitrocellulose filter with P4D10 and L31 (Fig. 3b) . The 45 kDa band precipitated by the anti-gp120 mAb P4D10 on infected .221.Cw4 cells was stained by L31 identifying it as HLA Cw4 heavy chain. Thus, on HIV infected cells HLA Cw4 molecules co-precipitate together with Env proteins.
Since the increased accessibility of V3 and CD4i epitopes on native gp120 derived from HLA Cw4 positive viruses was clearly associated with increased virus infectivity we conclude that HLA Cw4 molecules directly contribute to viral infectivity by interacting with Env. The question than arose whether such interaction would influence the susceptibility of the virus to neutralizing antibodies.
To this purpose we selected sequential sera from one HIV-infected individual collected at different time points after seroconversion. The sera had been previously characterized for their capacity to neutralize homologous and heterologous primary virus isolates. Serum Bx26 collected at month 6 after seroconversion (Bx26m6) neutralized none of 14 virus isolates, whereas sera collected after 21 (Bx26m21) and 30 months (Bx26m30) neutralized two of 14 and five of 11 isolates respectively [12] . The neutralizing titres against the homologous virus increased with time from seroconversion [12] . The sera were tested on HeLa P4 cells against BRU and NL4-3 viruses generated from .221 and .221.Cw4 cells (Fig.4) . The HLA Cw4 negative BRU virus was significantly more susceptible to neutralization compared to the HLA Cw4 positive virus. In contrast there were no differences in susceptibility to neutralization between HLA Cw4 negative and positive NL4-3 viruses. The same pattern of neutralization was obtained with sera obtained from two other HIV positive individuals.
Thus, for viruses whose infectivity is enhanced upon incorporation of HLA Cw4 molecules, the susceptibility to antibody neutralization is reduced. This effect may be due to a decreased shedding of gp120 from the infectious virions as the results of the interaction between Env and HLA Cw4 molecules. It is also possible that the gp120 site of interaction with HLA Cw4, which is unaccessible to antibodies on HLA Cw4 positive virions, may be important for neutralization.
Taken together the data show that virus incorporation of HLA Cw4 molecules has a profound influence on both, virus infectivity and virus susceptibility to neutralizing antibodies. It also appears that different viruses may differ significantly in their dependance on HLA Cw4 incorporation for infectivity. As an example, the infectivity of LAI and Bru is enhanced by HLA Cw4 incorporation, similarly to the effects observed with the primary isolates. This is not the case for the two other TCLA strains, NL4-3 and NDK. NL4-3 is a laboratory chimera with envelope from LAI and gag-pol from NY5 [21] . This could suggest that envelope sequences may not be involved in this phenomenon. However, the original LAI clone [9] and the LAI portion of the NL4-3 recombinant clone are different clones from the same isolate. The allignement of the Env amino acids sequences of LAI and NL4-3 (accession number: U26942 for NL4-3 and K02013 for LAI) revealed 16 substitutions in gp120 and five in gp41. Fifteen of the 16 gp120 amino acid substitutions are concentrated at the base of the V1/V2 loop whose involvement in the exposition of the CD4i epitopes has been documented. Since the virus incorporation of HLA Cw4 molecules is followed by modifications within the expression of CD4i epitopes (mAb 1.7b) we speculate that amino acids substitutions at the V1/V2 loop of NL4-3 may be associated to an enhanced expression of the CD4i epitopes and increased binding to the coreceptor in the absence of HLA class I incorporation. This analysis, although limited to only two envelope sequences suggests that the determinants for the HLA-dependant phenotype are located within envelope sequences.
The reduction in the susceptibility to neutralizing antibodies displayed by HLA Cw4 positive versus negative Bru viruses may have more general implications for understanding of the susceptibility to neutralization of different viral isolates. It is known that primary viruses are more refractory to neutralization than TCLA viruses [22] . This phenomenon may be directly related to the HLA-dependent phenotype of primary isolates. On the other hand, during the process of adaptation to in vitro culture on T-cell lines, that is, in the absence of neutralizing antibodies, the requirement for HLA incorporation for virus infectivity may become less stringent resulting in an augmented susceptibility to neutralization.
The question of the role of different HLA class I alleles in HIV infectivity was not addressed in this study. For all our experiments we used .221 cells transfected with the Cw4 allele since preliminary data indicated that HLA C molecules may be preferentially associated to HIV viral particles. Interestingly, a recent paper by Carrington et al. [23] demonstrates that homozygosity for the Cw4 and B35 alleles is consistently associated with rapid progression to AIDS in Caucasian population. As suggested by Carrington et al., the failure of these alleles to protect against AIDS progression may not reflect a simple failure to present HIV epitopes since both alleles have been reported to present HIV peptides to cytotoxic T lymphocytes [24] [25] [26] . Thus, it is possible that, some HLA class I loci may influence the outcome of HIV infection not only through epitope selection of immunocompetent cells but also by enhancing viral infectivity. Furthermore, the interaction of HLA class I molecules with viral envelope proteins may not only lead to increased infectivity but also to a decreased susceptibility to antibody neutralization thus favouring progression to disease.
